Pay in 4 interest-free payments of $7.04 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
Enjoy extra savings on every purchase
demonstrated in vitro the anti-leukemic activity of the novel CPT1A reversible inhibitor ST1326 on leukemia cell lines and primary cells obtained from patients with hematologic malignancies, which induces cell growth arrest, mitochondrial damage, and apoptosis 32
Thank you for your patience
An open-lable, single-arm trial of the safety and efficacy of a novel preparation of glutathione as a skin-ligheting agent in Filipino women
US$ 29.45
US$ 25.25
US$ 27.96
